Let's scratch the surface.

In the United States, atherosclerotic cardiovascular disease is a leading cause of death and disability for men, women, and people of most racial and ethnic groups.

let's dig deeper

There is a real unmet need.

Currently, there is no precise diagnostic tool that can effectively guide individualized therapy for patients with cardiovascular disease.

learn more

A big problem set us on an even bigger mission.

Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.

learn how we plan to fulfill it

Meet the future of precision diagnostics.

An innovative diagnostic test that is being developed to help doctors make more informed treatment decisions.

discover our test
latest news

August 16, 2022

Prolocor Announces a Combined $5.2 Million in Funding From Seed Round and NIH SBIR Grant

read more

January 10, 2022

Prolocor to Participate at Biotech Showcase 2022

read more

March 9, 2023

Prolocor Announces Appointment of Edward L. Rosen to Its Board of Directors

read more